The Roswell Park GMP Engineering & Cell Manufacturing Facility, or Roswell Park GEM, is the largest academic cell and gene therapy research and manufacturing facility in the U.S., according to a Dec. 16 news release from the cancer center.
One of the facility’s focuses will be developing cell and gene therapies to treat solid-tumor cancers, the release said.
Roswell Park recently appointed Michael Wong, MD, PhD, to serve as the center’s first physician-in-chief and is set to launch an oncology nurse scientist training program with a $2.11 million grant from the National Cancer Institute.
At the Becker's Perioperative Summit, taking place September 14–15 in Chicago, perioperative leaders and healthcare executives will focus on improving operating room efficiency, enhancing patient safety, optimizing staffing and driving innovation across surgical services. Apply for complimentary registration now.
